Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000589301 | SCV000525684 | benign | not provided | 2016-11-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001086199 | SCV000656022 | benign | Noonan syndrome 9 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589301 | SCV000698742 | benign | not provided | 2017-04-12 | criteria provided, single submitter | clinical testing | Variant summary: The SOS2 c.3075+7C>T variant involves the alteration of a non-conserved intronic nucleotide. 5/5 splice prediction tools predict no significant impact on normal splicing. This variant was found in 1055/121182 control chromosomes (including 7 homozygotes) from ExAC, predominantly observed in the European (Non-Finnish) subpopulation at a frequency of 0.011545 (770/66694). This frequency is about 4618 times the estimated maximal expected allele frequency of a pathogenic SOS2 variant (0.0000025), suggesting this is likely a benign polymorphism found primarily in the populations of European (Non-Finnish) origin. One clinical diagnostic laboratory has classified this variant as benign. The variant of interest has not, to our knowledge, been reported in literature. Taken together, this variant is classified as Benign. |
ARUP Laboratories, |
RCV001086199 | SCV001471007 | benign | Noonan syndrome 9 | 2023-08-23 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001813478 | SCV002060671 | benign | Noonan syndrome and Noonan-related syndrome | 2021-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000589301 | SCV002545174 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | SOS2: BP4, BS1, BS2 |
Genome- |
RCV001086199 | SCV002763012 | benign | Noonan syndrome 9 | criteria provided, single submitter | clinical testing | ||
Clinical Genetics, |
RCV001706634 | SCV001922832 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001706634 | SCV001959203 | benign | not specified | no assertion criteria provided | clinical testing |